Curie Co careers

Curie Co engineers enzymes and biomaterials to replace chemicals banned by the FDA in consumer products. We have developed an antimicrobial, biodegradable polymer to address the gap in consumer soap and medical devices affected by recent and pending regulations.
Broad restrictions by the FDA are expected in coming months which will impact a $70 Bn market: Antimicrobials & Antimicrobial Resistance ($35.6 Bn), OTC Market ($32 Bn), Wound Care ($10 Bn), and Soap & Shower ($5.5 Bn). Curie Co is positioned to address the OTC and cosmetic markets affected by these new FDA regulations.
Regulations enacted over the last 18 mo will directly impact consumer products by prohibiting:
Antimicrobials - triclosan and 18 related compounds prohibited from use in hand soap
Microbeads - banned from wash-off products
With the exclusion of antimicrobial actives and microbeads, over 40% of soaps and roughly 18% of OTCs sold in the US must be relabeled and reformulated to comply with new FDA regulations.